New Two-Pronged attack on Tough-to-Treat prostate cancer
NCT ID NCT05730712
Summary
This study tested a new combination of drugs for men with advanced prostate cancer that had spread and was no longer responding to standard hormone-blocking treatments. It combined a pill (enzalutamide) with two targeted antibody drugs given as an injection to see if attacking the cancer in two different ways would be more effective. The main goal was to see if the treatment could shrink tumors and control the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IVB PROSTATE CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.